MedPath

Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients

Phase 3
Completed
Conditions
HIV Infections
Registration Number
NCT00002450
Lead Sponsor
Gilead Sciences
Brief Summary

The purpose of this study is to see if giving tenofovir DF plus a combination of other anti-HIV drugs is safe and effective.

Detailed Description

Patients are randomized 2:1 to add tenofovir DF once daily or placebo to their existing antiretroviral regimen in a blinded manner. Patients are stratified according to HIV-1 RNA level, CD4 cell count, and number of antiretroviral drugs taken prior to study entry. Patients and physicians are strongly discouraged from making changes in their antiviral therapies for at least 24 weeks post-randomization. After Week 24, changes in background antiretroviral therapy are permitted. At 24 weeks post-randomization, patients randomized to receive placebo are crossed over to receive open-label tenofovir DF once daily for the remainder of the 48-week study. While on study drug, patients are monitored for safety using periodic physical examinations and serial laboratory tests. Additionally, changes in plasma HIV RNA levels and CD4 cell counts are monitored to assess antiviral efficacy. At the end of the 48-week study period, patients are rolled over into extended dosing until tenofovir DF is commercially available or Gilead Sciences terminates the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
600
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (61)

Tower Infectious Diseases / Med Associates Inc

🇺🇸

Los Angeles, California, United States

Remington Davis Inc

🇺🇸

Columbus, Ohio, United States

Thomas Street Clinic

🇺🇸

Houston, Texas, United States

Univ of Texas / Thomas Street Clinic

🇺🇸

Houston, Texas, United States

AIDS Research Consortium of Atlanta Inc

🇺🇸

Atlanta, Georgia, United States

Univ of Rochester Medical Center

🇺🇸

Rochester, New York, United States

Howard Grossman

🇺🇸

New York, New York, United States

St Vincent's Hosp

🇺🇸

New York, New York, United States

Brookdale Univ Hosp and Med Ctr

🇺🇸

Brooklyn, New York, United States

Nicholas Bellos

🇺🇸

Dallas, Texas, United States

Pennsylvania State College of Medicine

🇺🇸

Hershey, Pennsylvania, United States

Miriam Hosp / Brown Univ

🇺🇸

Providence, Rhode Island, United States

Hampton Roads Med Specialists

🇺🇸

Hampton, Virginia, United States

Infections Ltd / Physicians Med Ctr

🇺🇸

Tacoma, Washington, United States

Regions Hosp / HIV/AIDS Program

🇺🇸

St. Paul, Minnesota, United States

Univ of Colorado / Health Science Ctr

🇺🇸

Denver, Colorado, United States

UCSD Med Ctr - Owen Clinic

🇺🇸

San Diego, California, United States

San Francisco VA Med Ctr

🇺🇸

San Francisco, California, United States

Univ of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

Cedars Sinai Med Ctr

🇺🇸

Los Angeles, California, United States

Robert Scott MD

🇺🇸

Oakland, California, United States

St Mary's Med Ctr

🇺🇸

Long Beach, California, United States

Kaiser Permanente LAMC

🇺🇸

Los Angeles, California, United States

Kaiser Foundation Hospital

🇺🇸

San Francisco, California, United States

Bronx Lebanon Hosp Ctr

🇺🇸

Bronx, New York, United States

AIDS Healthcare Foundation-Research Center

🇺🇸

Los Angeles, California, United States

Albany Med College

🇺🇸

Albany, New York, United States

Harbor UCLA Med Ctr / Research and Educational Institute

🇺🇸

Torrance, California, United States

Dallas Veterans Administration Med Ctr

🇺🇸

Dallas, Texas, United States

Univ of NM

🇺🇸

Albuquerque, New Mexico, United States

Ponce de Leon Med Ctr

🇺🇸

Atlanta, Georgia, United States

Ian Baird

🇺🇸

Columbus, Ohio, United States

Columbia Univ

🇺🇸

New York, New York, United States

Oklahoma Univ Health Science Ctr

🇺🇸

Oklahoma City, Oklahoma, United States

Hillsborough County Health Dept

🇺🇸

Tampa, Florida, United States

Ponce Univ Hosp

🇵🇷

Ponce, Puerto Rico

Ocean View Internal Medicine

🇺🇸

Long Beach, California, United States

LAC / USC Med Ctr / Infectious Diseases

🇺🇸

Los Angeles, California, United States

Pacific Horizons Med Group

🇺🇸

San Francisco, California, United States

Physicans Home Service

🇺🇸

Washington, District of Columbia, United States

Northstar Med Clinic

🇺🇸

Chicago, Illinois, United States

Bendel Med Research

🇺🇸

Lafayette, Louisiana, United States

Nalle Clinic / Clinical Research Dept

🇺🇸

Charlotte, North Carolina, United States

Univ TX San Antonio Health Science Ctr

🇺🇸

San Antonio, Texas, United States

Infectious Diseases Physicians Inc

🇺🇸

Annandale, Virginia, United States

Infections Ltd PS

🇺🇸

Puyallup, Washington, United States

Steinhart Medical Associates

🇺🇸

Miami, Florida, United States

Univ of Miami School of Medicine

🇺🇸

Miami, Florida, United States

Phoenix Body Positive

🇺🇸

Phoenix, Arizona, United States

Harper Hosp

🇺🇸

Detroit, Michigan, United States

Massachusetts Gen Hosp

🇺🇸

Boston, Massachusetts, United States

Therafirst Med Ctr

🇺🇸

Fort Lauderdale, Florida, United States

Yale-New Haven Hospital

🇺🇸

New Haven, Connecticut, United States

Clinical Research Puerto Rico Inc

🇵🇷

San Juan, Puerto Rico

San Juan AIDS Program

🇵🇷

Santurce, Puerto Rico

George Washington Univ Med Ctr

🇺🇸

Washington, District of Columbia, United States

ARTCTC

🇺🇸

Fort Pierce, Florida, United States

Treasure Coast Infectious Disease Consultants

🇺🇸

Vero Beach, Florida, United States

Dr Joel Gallant

🇺🇸

Baltimore, Maryland, United States

New England Med Ctr

🇺🇸

Boston, Massachusetts, United States

Yale New Haven Hosp / Nathan Smith Clinic

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath